These 3 Aussie stocks could skyrocket and stay there for decades

Let's see what sets these stocks apart from the rest.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • CSL Ltd, a biotechnology leader with a robust plasma collection network and extensive R&D investment, offers high barriers to entry and future growth prospects despite recent share price pressure.
  • Pro Medicus, known for its Visage medical imaging platform, enjoys high margins and growth potential with sticky recurring revenues from long-term U.S. contracts, positioned to benefit from global healthcare digitization.
  • WiseTech Global, with its indispensable CargoWise platform in logistics, maintains a dominant market position with high switching costs and is poised for long-term growth through global trade expansion and strategic acquisitions.

Every now and then, the ASX delivers stocks with the potential not only to climb higher but to keep delivering for shareholders long after the initial run-up.

These are the kinds of businesses with strong competitive advantages, huge global markets, and management teams that know how to execute.

Let's now look at three Aussie stocks that tick these boxes and could be destined to skyrocket — and stay there for decades.

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.

Image source: Getty Images

CSL Ltd (ASX: CSL)

CSL is a biotechnology giant that has turned into one of Australia's greatest corporate success stories. With its plasma therapies, vaccines, and specialty treatments, this Aussie stock has built a global footprint that few rivals can match.

What makes CSL so attractive for long-term investors is its moat. The company operates one of the world's largest plasma collection networks and reinvests heavily into research and development each year. This combination creates high barriers to entry and a pipeline of new treatments to fuel future growth.

While its share price has been under pressure recently, history suggests that CSL has the resilience and the innovation to keep compounding earnings well into the future.

Pro Medicus Ltd (ASX: PME)

Another Aussie stock to look at is Pro Medicus. It is a medical imaging software provider that's taking the healthcare world by storm. Its Visage platform allows hospitals and radiologists to view, share, and analyse images faster and more efficiently than traditional systems.

Once installed, Visage generates sticky recurring revenues from long-term contracts, particularly in the U.S. healthcare system. With major hospitals already on board and new deals being signed, Pro Medicus has plenty of room to grow.

Its margins are among the best on the ASX, and with the digitisation of healthcare accelerating globally, Pro Medicus could remain a top performer for decades.

WiseTech Global Ltd (ASX: WTC)

Finally, WiseTech Global has become an indispensable player in the logistics industry. The Aussie stock's CargoWise platform is used worldwide by freight forwarders, customs brokers, and transport companies to manage supply chains.

The company has carved out a dominant position by offering a single, integrated solution that replaces clunky, outdated systems. Its customer base is sticky, with high switching costs that make it difficult for rivals to compete.

With global trade volumes expected to keep rising and WiseTech expanding its product suite with acquisitions, its long-term growth potential is enormous. For investors, it could be a classic example of an ASX tech company with global scalability.

Motley Fool contributor James Mickleboro has positions in CSL, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Buy and sell written on a white cube.
Growth Shares

2 ASX shares highly recommended to buy: Experts

These businesses have a lot going for them…

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Growth Shares

3 ASX 200 shares that could beat the market over the next 10 years

Outperforming the market isn’t easy, but some companies have the qualities needed to do it.

Read more »

A smiling woman with a handful of $100 notes, indicating strong dividend payments
Growth Shares

Where to invest $3,000 in ASX growth shares in April

Money to invest next month? Here are three shares with bucketloads of growth potential.

Read more »

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
Growth Shares

Top Australian shares to buy right now with $2,500

These shares look attractive after recent market volatility.

Read more »

Person using a calculator with four piles of coins, each getting higher, with trees on them.
Growth Shares

Experts rate these 2 ASX growth shares as buys this month!

These businesses have plenty of positives according to analysts.

Read more »

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Growth Shares

3 ASX shares being unfairly punished by the market selloff and could rise 100%

Analysts think these shares could rebound strongly after heavy declines.

Read more »

Two players on a field pump their fists in the air, indicating two of the best
Growth Shares

2 amazing ASX shares to buy for long-term growth

Both billion dollar stocks combine strong growth, scalability and a leadership position.

Read more »

A beautiful woman holds up one finger with one hand and has her hand on her waist with the other as she smiles widely as though she is very pleased about something.
Growth Shares

2 ASX 200 shares that now have 60% upside: Analysts

With markets under pressure, some ASX 200 shares are starting to look more interesting. Here are two that stand out…

Read more »